Zobrazeno 1 - 10
of 267
pro vyhledávání: '"Ribolla, R."'
Autor:
Autore F; Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario 'A. Gemelli' IRCCS. francesco.autore@policlinicogemelli.it., Bramanti S; Istituto Clinico Humanitas IRCCS, Rozzano., Lessi F; Azienda Ospedale Università Padova, Padova., Innocenti I; Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario 'A. Gemelli' IRCCS., Galli E; Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario 'A. Gemelli' IRCCS., Rocchi S; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia 'Seràgnoli', Bologna; Dipartimento di Scienze Mediche e Chirurgiche, Università di Bologna, Bologna., Ribolla R; Spedali Civili, Brescia., Derudas D; SC di Ematologia e CTMO - Oncologico Oncologico di Riferimento Regionale 'A. Businco' - ARNAS 'G. Brotzu' - Cagliari., Oliva S; S. Giovanni Battista, Torino., Stefanoni P; ASST Papa Giovanni XXIII, Bergamo., Marcatti M; San Raffaele, Milano., Schenone A; Department of Neurosciences, Rehabilitation, Ophthalmology, Genetic and Maternal and Infantile Sciences (DINOGMI), University of Genoa; IRCCS San Martino Hospital, Genova., La Nasa G; SC di Ematologia e CTMO - Oncologico Oncologico di Riferimento Regionale 'A. Businco' - ARNAS 'G. Brotzu' - Cagliari., Crippa C; Spedali Civili, Brescia., Zamagni E; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia 'Seràgnoli', Bologna; Dipartimento di Scienze Mediche e Chirurgiche, Università di Bologna, Bologna., Riva M; Azienda Ospedale Università Padova, Padova., Mazza R; Istituto Clinico Humanitas IRCCS, Rozzano., Mannina D; Istituto Clinico Humanitas IRCCS, Rozzano., Sica S; Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario 'A. Gemelli' IRCCS, Roma; Sezione di Ematologia, Dipartimento di Scienze Radiologiche ed Ematologiche, Università Cattolica del Sacro Cuore., Bacigalupo A; Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario 'A. Gemelli' IRCCS, Roma; Sezione di Ematologia, Dipartimento di Scienze Radiologiche ed Ematologiche, Università Cattolica del Sacro Cuore., Laurenti L; Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario 'A. Gemelli' IRCCS, Roma; Sezione di Ematologia, Dipartimento di Scienze Radiologiche ed Ematologiche, Università Cattolica del Sacro Cuore.
Publikováno v:
Haematologica [Haematologica] 2024 Mar 01; Vol. 109 (3), pp. 888-894. Date of Electronic Publication: 2024 Mar 01.
Autor:
Belotti A; Department of Hematology, ASST Spedali Civili, Brescia, Italy., Ribolla R; Department of Hematology, ASST Spedali Civili, Brescia, Italy., Crippa C; Department of Hematology, ASST Spedali Civili, Brescia, Italy., Chiarini M; Clinical Chemistry Laboratory/Diagnostic Department, ASST Spedali Civili, Brescia, Italy., Giustini V; Clinical Chemistry Laboratory/Diagnostic Department, ASST Spedali Civili, Brescia, Italy., Ferrari S; Department of Hematology, ASST Spedali Civili, Brescia, Italy., Peli A; Department of Hematology, ASST Spedali Civili, Brescia, Italy., Cattaneo C; Department of Hematology, ASST Spedali Civili, Brescia, Italy., Roccaro A; Clinical Trial Center, Translational Research and Phase I Unit, ASST Spedali Civili, Brescia, Italy., Frittoli B; Department of Radiology, ASST Spedali Civili, Brescia, Italy., Grazioli L; Department of Radiology, ASST Spedali Civili, Brescia, Italy., Rossi G; Department of Hematology, ASST Spedali Civili, Brescia, Italy., Tucci A; Department of Hematology, ASST Spedali Civili, Brescia, Italy.
Publikováno v:
American journal of hematology [Am J Hematol] 2023 Sep; Vol. 98 (9), pp. E230-E232. Date of Electronic Publication: 2023 Jun 15.
Autor:
Lesokhin A; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York City, New York, USA., LeBlanc R; Division of Hematology, Oncology and Transplantation, Department of Medicine, Maisonneuve-Rosemont Hospital, Université de Montréal, Montréal, Qubec, Canada., Dimopoulos MA; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece., Capra M; Centro Integrado de Hematologia e Oncologia, Hospital Mãe de Deus, Porto Alegre, Brazil., Carlo-Stella C; Department of Biomedical Sciences, Humanitas University, Rozzano-Milan, Italy.; Department of Oncology and Hematology, IRCCS - Humanitas Research Hospital, Rozzano-Milan, Italy., Karlin L; Department of Hematology, Hôpital Lyon-Sud, Hospices Civils de Lyon, Université Claude Bernard Lyon 1, Lyon, France., Castilloux JF; Centre Hospitalier Universitaire de Sherbrooke, Division of Hematology and Medical Oncology, Université de Sherbrooke, Sherbrooke, Canada., Forsberg P; Department of Medicine, Division of Hematology, University of Colorado School of Medicine, Aurora, Colorado, USA., Parmar G; Department of Haematology, Wollongong Hospital, Wollongong, New South Wales, Australia., Tosikyan A; Hôpital du Sacré-Coeur de Montréal, Montréal, Qubec, Canada., Pour L; Department of Internal Medicine, University Hospital Brno, Brno, Czech Republic., Ribrag V; Department of Hematology, Gustave Roussy, Université Paris-Saclay, Villejuif, France., Ribolla R; Department of Hematology, ASST Spedali Civili di Brescia, Brescia, Italy., Abdallah AO; Division of Hematological Malignancies and Cellular Therapeutics, University of Kansas, Lawrence, Kansas, USA., Le Roux N; Sanofi Research & Development on behalf of Altran, Vitry-sur-Seine, France., Dong L; Sanofi, Beijing, China., van de Velde H; Sanofi, Cambridge, Massachusetts, USA., Mayrargue L; Sanofi Research & Development, Chilly-Mazarin, France., Lépine L; Sanofi Clinical Pharmacokinetics on behalf of Excelya, Chilly-Mazarin, France., Macé S; Sanofi Research & Development, Vitry-sur-Seine, France., Moreau P; Hematology Department, CHU Nantes, Nantes, France.
Publikováno v:
Cancer medicine [Cancer Med] 2023 May; Vol. 12 (9), pp. 10254-10266. Date of Electronic Publication: 2023 Mar 03.
Autor:
Sacco A; Clinical Research Development and Phase I Unit, CREA Laboratory, ASST Spedali Civili di Brescia, Brescia, Italy., Federico C; Clinical Research Development and Phase I Unit, CREA Laboratory, ASST Spedali Civili di Brescia, Brescia, Italy., Todoerti K; Hematology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy., Ziccheddu B; Department of Molecular Biotechnologies and Health Sciences, University of Turin, Turin, Italy., Palermo V; Clinical Research Development and Phase I Unit, CREA Laboratory, ASST Spedali Civili di Brescia, Brescia, Italy., Giacomini A; Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy., Ravelli C; Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy., Maccarinelli F; Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy., Bianchi G; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Belotti A; Hematology, ASST Spedali Civili di Brescia, Brescia, Italy., Ribolla R; Hematology, ASST Spedali Civili di Brescia, Brescia, Italy., Favasuli V; Hematology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Revenko AS; Ionis Pharmaceuticals, Carlsbad, CA., Macleod AR; Ionis Pharmaceuticals, Carlsbad, CA., Willis B; Oncology R &D, AstraZeneca, Waltham, MA., Cai H; Oncology R &D, AstraZeneca, Waltham, MA., Hauser J; Oncology R &D, AstraZeneca, Cambridge, United Kingdom; and., Rooney C; Oncology R &D, AstraZeneca, Cambridge, United Kingdom; and., Willis SE; Oncology R &D, AstraZeneca, Cambridge, United Kingdom; and., Martin PL; Translational Medicine, Oncology R&D, AstraZeneca, Gaithersburg, MD., Staniszewska A; Oncology R &D, AstraZeneca, Cambridge, United Kingdom; and., Ambrose H; Oncology R &D, AstraZeneca, Cambridge, United Kingdom; and., Hanson L; Oncology R &D, AstraZeneca, Cambridge, United Kingdom; and., Cattaneo C; Hematology, ASST Spedali Civili di Brescia, Brescia, Italy., Tucci A; Hematology, ASST Spedali Civili di Brescia, Brescia, Italy., Rossi G; Hematology, ASST Spedali Civili di Brescia, Brescia, Italy., Ronca R; Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy., Neri A; Hematology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Mitola S; Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy., Bolli N; Hematology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Presta M; Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy., Moschetta M; Oncology R &D, AstraZeneca, Cambridge, United Kingdom; and., Ross S; Oncology R &D, AstraZeneca, Cambridge, United Kingdom; and., Roccaro AM; Clinical Research Development and Phase I Unit, CREA Laboratory, ASST Spedali Civili di Brescia, Brescia, Italy.
Publikováno v:
Blood [Blood] 2021 Nov 04; Vol. 138 (18), pp. 1705-1720.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Belotti A; Department of Hematology, ASST Spedali Civili di Brescia, Brescia, Italy., Ribolla R; Department of Hematology, ASST Spedali Civili di Brescia, Brescia, Italy., Cancelli V; Department of Hematology, ASST Spedali Civili di Brescia, Brescia, Italy., Villanacci A; Department of Radiology, ASST Spedali Civili di Brescia, Brescia, Italy., Angelini V; Department of Radiology, ASST Spedali Civili di Brescia, Brescia, Italy., Chiarini M; Clinical Chemistry Laboratory, Diagnostic Department, ASST Spedali Civili di Brescia, Brescia, Italy., Giustini V; Clinical Chemistry Laboratory, Diagnostic Department, ASST Spedali Civili di Brescia, Brescia, Italy., Facchetti GV; Department of Hematology, ASST Spedali Civili di Brescia, Brescia, Italy., Roccaro AM; Clinical Research Development and Phase I Unit, ASST Spedali Civili di Brescia, Brescia, Italy., Ferrari S; Department of Hematology, ASST Spedali Civili di Brescia, Brescia, Italy., Peli A; Department of Hematology, ASST Spedali Civili di Brescia, Brescia, Italy., Bottelli C; Department of Hematology, ASST Spedali Civili di Brescia, Brescia, Italy., Cattaneo C; Department of Hematology, ASST Spedali Civili di Brescia, Brescia, Italy., Crippa C; Department of Hematology, ASST Spedali Civili di Brescia, Brescia, Italy., Micilotta M; Department of Radiology, ASST Spedali Civili di Brescia, Brescia, Italy., Frittoli B; Department of Radiology, ASST Spedali Civili di Brescia, Brescia, Italy., Grazioli L; Department of Radiology, ASST Spedali Civili di Brescia, Brescia, Italy., Rossi G; Department of Hematology, ASST Spedali Civili di Brescia, Brescia, Italy., Tucci A; Department of Hematology, ASST Spedali Civili di Brescia, Brescia, Italy.
Publikováno v:
Cancer medicine [Cancer Med] 2021 Sep; Vol. 10 (17), pp. 5859-5865. Date of Electronic Publication: 2021 Jul 15.
Autor:
Oliva S; Myeloma Unit, Division of Hematology, University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Torino, Italy. stefania.olivamolinet@gmail.com., Bruinink DHO; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Laboratory Medical Immunology, Department of Immunology, Erasmus University Medical Center, Rotterdam, The Netherlands., Rihova L; Department of Clinical Hematology, University Hospital Brno, Brno, Czech Republic., D'Agostino M; Myeloma Unit, Division of Hematology, University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Torino, Italy., Pantani L; Azienda Ospedaliero-Universitaria di Bologna, Seràgnoli Institute of Hematology, Department of Experimental, Diagnostic and Specialty Medicine, Bologna University School of Medicine, S Orsola Malpighi Hospital, Bologna, Italy., Capra A; Myeloma Unit, Division of Hematology, University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Torino, Italy., van der Holt B; HOVON Data Center, Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Troia R; Myeloma Unit, Division of Hematology, University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Torino, Italy., Petrucci MT; Hematology, Department of Translational and Precision Medicine, Azienda Ospedaliera Policlinico Umberto I, Sapienza University of Rome, Rome, Italy., Villanova T; Myeloma Unit, Division of Hematology, University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Torino, Italy., Vsianska P; Department of Clinical Hematology, University Hospital Brno, Brno, Czech Republic., Jugooa R; Department of Immunology, Laboratory Medical Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands., Brandt-Hagens C; Department of Immunology, Laboratory Medical Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands., Gilestro M; Myeloma Unit, Division of Hematology, University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Torino, Italy., Offidani M; Clinica di Ematologia, Azienda Ospedaliero Universitaria Ospedali Riuniti Umberto I-G.M. Lancisi-G. Salesi di Ancona, Ancona, Italy., Ribolla R; Division of Hematology, ASST Spedali Civili di Brescia, Brescia, Italy., Galli M; Dipartimento di Oncologia ed Ematologia, ASST Papa Giovanni XXIII, Bergamo, Italy., Hajek R; Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic.; Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic., Gay F; Myeloma Unit, Division of Hematology, University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Torino, Italy., Cavo M; Azienda Ospedaliero-Universitaria di Bologna, Seràgnoli Institute of Hematology, Department of Experimental, Diagnostic and Specialty Medicine, Bologna University School of Medicine, S Orsola Malpighi Hospital, Bologna, Italy., Omedé P; Myeloma Unit, Division of Hematology, University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Torino, Italy., van der Velden VHJ; Department of Immunology, Laboratory Medical Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands., Boccadoro M; Myeloma Unit, Division of Hematology, University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Torino, Italy., Sonneveld P; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Publikováno v:
Blood cancer journal [Blood Cancer J] 2021 Jun 03; Vol. 11 (6), pp. 106. Date of Electronic Publication: 2021 Jun 03.
Autor:
Çakan, Elif1,2 (AUTHOR) 1elifcakan@gmail.com, Lara, Olivia D.3,4 (AUTHOR) odlara@med.unc.edu, Szymanowska, Anna1 (AUTHOR) szymanowska_anna@wp.pl, Bayraktar, Emine1,5 (AUTHOR) ebayraktar@mdanderson.org, Chavez-Reyes, Arturo6 (AUTHOR) arturochavez@uft.cl, Lopez-Berestein, Gabriel1 (AUTHOR) glopez@mdanderson.org, Amero, Paola1 (AUTHOR) PAmero@mdanderson.org, Rodriguez-Aguayo, Cristian1,3 (AUTHOR) CRodriguez2@mdanderson.org
Publikováno v:
Cancers. Sep2024, Vol. 16 Issue 17, p2940. 35p.
Autor:
Namdaroğlu, Sinem1 (AUTHOR) semih.basci@gmail.com, Başcı, Semih1 (AUTHOR), Aslan Candır, Burcu2 (AUTHOR) bcandir@yahoo.com, Yaman, Samet2 (AUTHOR) syaman@yahoo.com, Yiğenoğlu, Tuğçe Nur2 (AUTHOR) tnur@gmail.com, Bahsi, Taha3 (AUTHOR) tbasi@gmail.com, Özcan, Nurgül2 (AUTHOR) sdal@yahoo.com, Dal, Mehmet Sinan2 (AUTHOR) mcakar@gmail.com, Kızıl Çakar, Merih2 (AUTHOR) faltunt@yahoo.com, Altuntaş, Fevzi2 (AUTHOR)
Publikováno v:
Journal of Clinical Medicine. Sep2024, Vol. 13 Issue 17, p5145. 9p.
Autor:
Malagola, Michele, Skert, C., Borlenghi, E., Chiarini, M., Giustini, V., Comini, F., Cattina, F., Cancelli, V., Cerqui, E., Farina, M., Pagani, C., Passi, A., Schieppati, F., Ribolla, R., Ruggeri, G., Caimi, Luigi, Russo, Domenico, Rossi, G.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3662::dbcea26526c1d2c1794860878b90b507
http://hdl.handle.net/11379/471222
http://hdl.handle.net/11379/471222